603368 柳藥集團
按盤價 
20.310 +0.280 (+1.398%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.582 | 12.005 | 13.500 | 12.276 | 10.680 |
| 總資產報酬率 ROA (%) | 2.023 | 4.127 | 4.383 | 4.069 | 3.675 |
| 投入資產回報率 ROIC (%) | 2.669 | 5.625 | 5.975 | 5.601 | 5.071 | 邊際利潤分析 |
| 銷售毛利率 (%) | 11.070 | 11.366 | 11.889 | 11.505 | 11.416 |
| 營業利潤率 (%) | 4.903 | 4.738 | 5.015 | 4.672 | 4.395 |
| 息稅前利潤/營業總收入 (%) | 5.909 | 5.846 | 6.212 | 5.829 | 5.596 |
| 淨利潤/營業總收入 (%) | 4.256 | 4.096 | 4.356 | 3.984 | 3.741 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 102.617 | 101.247 | 104.038 | 104.008 | 102.636 |
| 價值變動淨收益/利潤總額(%) | -0.000 | -0.009 | -0.068 | 0.832 | 0.264 |
| 營業外收支淨額/利潤總額(%) | -1.202 | -0.046 | -0.029 | 0.038 | 0.211 | 償債能力分析 |
| 流動比率 (X) | 1.626 | 1.570 | 1.491 | 1.489 | 1.551 |
| 速動比率 (X) | 1.352 | 1.347 | 1.292 | 1.262 | 1.342 |
| 資產負債率 (%) | 61.828 | 62.683 | 64.961 | 65.791 | 63.424 |
| 帶息債務/全部投入資本 (%) | 50.956 | 47.519 | 52.514 | 52.370 | 48.575 |
| 股東權益/帶息債務 (%) | 90.930 | 104.032 | 84.171 | 84.625 | 97.040 |
| 股東權益/負債合計 (%) | 59.282 | 57.189 | 50.533 | 48.760 | 54.229 |
| 利息保障倍數 (X) | 5.552 | 5.265 | 5.183 | 5.044 | 4.697 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 187.443 | 178.818 | 165.680 | 151.143 | 143.390 |
| 存貨周轉天數 (天) | 56.555 | 47.443 | 46.806 | 45.557 | 39.983 |
| 備註： | 即時報價更新時間為 19/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
